A longitudinal study on fluconazole resistance in Candida albicans vaginal isolates
- 13 March 2023
- Vol. 66 (7), 563-565
- https://doi.org/10.1111/myc.13582
Abstract
BackgroundRecurrent vulvovaginal candidiasis (RVVC), despite its worldwide prevalence, has limited treatment options; and a long-term prophylactic regimen utilising fluconazole is the dominant choice. ObjectivesAn increase in fluconazole resistance is reported, and little information is available about the reversibility of resistance status following the withdrawal of fluconazole. MethodsRepeated antifungal susceptibility tests (ASTs) for fluconazole at a median interval of 3 months between them were evaluated in women with refractory or recurrent VVC patients at the Vaginitis clinic from 2012 to 2021 (10 years) and performed at pH 7 and pH 4.5 using the broth microdilution tests based on the CLSI M27-A4 reference method. ResultsOf 38 patients with long-term follow-up with repeat ASTs, 13 patients (13/38, 34.2%) tested at pH 7.0 remained susceptible to fluconazole with MIC <= 2 mu g/mL. Nineteen patients (19/38, 50%) remained resistant to fluconazole with MIC >= 8 mu g/mL, whereas four (4/38, 10.5%) changed from susceptible to resistant and two (2/38, 5.2%) changed from resistant to susceptible over time. At pH 4.5, among the 37 patients with repeated MIC values, nine (9/37, 24.3%) remained susceptible to fluconazole and 22 (22/37, 59.5%) remained resistant. Three isolates (3/37, 8.1%) changed from susceptible to resistant, while 3 (3/37, 8.1%) changed from resistant to susceptible over time. ConclusionFluconazole susceptibility in Candida albicans vaginal isolates obtained longitudinally in women with RVVC remains stable with rare reversal of resistance despite azole avoidance.Keywords
This publication has 20 references indexed in Scilit:
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2015
- Recurrent vulvovaginal candidiasisAmerican Journal of Obstetrics and Gynecology, 2015
- Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpressionMycoses, 2014
- Prevalence of Recurrent Vulvovaginal Candidiasis in 5 European Countries and the United StatesJournal of Lower Genital Tract Disease, 2013
- Effect of pH on In Vitro Susceptibility of Candida glabrata and Candida albicans to 11 Antifungal Agents and Implications for Clinical UseAntimicrobial Agents and Chemotherapy, 2012
- The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: A mycological perspectiveCritical Reviews in Microbiology, 2011
- Genotype distribution of Candida albicans strains associated with different conditions of vulvovaginal candidiasis, as revealed by microsatellite typingSexually Transmitted Infections, 2008
- Vulvovaginal candidosisThe Lancet, 2007
- Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasisObstetrics & Gynecology, 2002
- VaginitisThe New England Journal of Medicine, 1997